G Moro

405 total citations
16 papers, 196 citations indexed

About

G Moro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, G Moro has authored 16 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in G Moro's work include Cancer Treatment and Pharmacology (4 papers), Genetic factors in colorectal cancer (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). G Moro is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Genetic factors in colorectal cancer (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). G Moro collaborates with scholars based in Italy, India and Argentina. G Moro's co-authors include Luigi Dogliotti, A. Farris, Francesco Deltetto, Alberto Bottini, Marco Tampellini, G. Gorzegno, Alfredo Berruti, Paolo Zola, M. Torta and Aldo Gerbino and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and British Journal of Cancer.

In The Last Decade

G Moro

16 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Moro Italy 7 112 69 62 45 26 16 196
Shailesh Bondarde India 8 152 1.4× 71 1.0× 56 0.9× 74 1.6× 11 0.4× 25 237
Carole Massabeau France 9 68 0.6× 30 0.4× 78 1.3× 56 1.2× 40 1.5× 32 196
Rosaria Cesaraccio Italy 10 139 1.2× 72 1.0× 76 1.2× 51 1.1× 8 0.3× 14 243
David Papadimos Australia 8 87 0.8× 62 0.9× 43 0.7× 70 1.6× 7 0.3× 11 205
Gabit Alipov Japan 8 90 0.8× 73 1.1× 27 0.4× 43 1.0× 12 0.5× 8 179
Artur M Burylo Netherlands 8 206 1.8× 137 2.0× 58 0.9× 52 1.2× 6 0.2× 10 303
Chiara Tuccilli Italy 11 109 1.0× 73 1.1× 37 0.6× 36 0.8× 9 0.3× 17 302
S. Suchetha India 9 55 0.5× 48 0.7× 32 0.5× 25 0.6× 19 0.7× 35 235
Silvana Acquafredda Italy 6 159 1.4× 42 0.6× 40 0.6× 94 2.1× 19 0.7× 8 237
A. Martoni Italy 7 101 0.9× 38 0.6× 26 0.4× 67 1.5× 18 0.7× 23 153

Countries citing papers authored by G Moro

Since Specialization
Citations

This map shows the geographic impact of G Moro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Moro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Moro more than expected).

Fields of papers citing papers by G Moro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Moro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Moro. The network helps show where G Moro may publish in the future.

Co-authorship network of co-authors of G Moro

This figure shows the co-authorship network connecting the top 25 collaborators of G Moro. A scholar is included among the top collaborators of G Moro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Moro. G Moro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Moro, G, et al.. (2023). Point‐of‐Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip. Angewandte Chemie. 135(51). 1 indexed citations
3.
Maurizi, Francesca, Alberto Bonetta, Roberto Bortolus, et al.. (2011). 499 oral SALVAGE OR ADJUVANT? 5Y-RESULTS OF THE “AIRO NATIONAL WORKING GROUP ON PROSTATE RADIOTHERAPY” MULTICENTER PROSPECTIVE STUDY. Radiotherapy and Oncology. 99. S202–S202. 1 indexed citations
4.
Donadio, Michela, Alfredo Berruti, Alberto Bottini, et al.. (2001). Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. Cancer Chemotherapy and Pharmacology. 47(5). 391–396. 8 indexed citations
5.
Tampellini, Marco, Alfredo Berruti, G. Gorzegno, et al.. (2001). Independent Factors Predict Supranormal CA 15-3 Serum Levels in Advanced Breast Cancer Patients at First Disease Relapse. Tumor Biology. 22(6). 367–373. 14 indexed citations
6.
Dogliotti, Luigi, Silvio Danese, Alfredo Berruti, et al.. (1998). Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. Cancer Chemotherapy and Pharmacology. 41(4). 333–338. 23 indexed citations
7.
Boschetto, Piera, et al.. (1998). [Asthma and rhinoconjunctivitis caused by rape flour: description of a clinical case].. PubMed. 89(3). 226–31. 3 indexed citations
8.
Tampellini, Marco, Aldo Gerbino, M. Torta, et al.. (1997). Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease. British Journal of Cancer. 75(5). 698–702. 69 indexed citations
9.
Berruti, Alfredo, Paolo Zola, A. Farris, et al.. (1997). Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival.. PubMed. 17(4A). 2763–8. 17 indexed citations
10.
Dogliotti, Luigi, Alfredo Berruti, Paolo Zola, et al.. (1996). Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.. Journal of Clinical Oncology. 14(4). 1165–1172. 44 indexed citations
11.
Gabriele, P., Riccardo Ragona, Monica Rampino, et al.. (1996). 50 An interim analysis of phase III study on radiothera (RT) versus RT plus carbolatin (CBDCA) in inoperab stage III–IV head and neck (H&N) carcinoma. Radiotherapy and Oncology. 40. S15–S15. 2 indexed citations
12.
Moro, G, et al.. (1991). [Combination of malignant tumors of the genitourinary system in the same patient: testicular seminoma, renal adenocarcinoma and adenocarcinoma of the prostate].. PubMed. 44(1). 73–5. 1 indexed citations
13.
Bevilacqua, Alessia, et al.. (1988). [A case of strangulated Littré's hernia in right inguinal site].. PubMed. 43(10). 875–6. 2 indexed citations
14.
Moro, G, et al.. (1982). The protective effect of fenoterol and salbutamol on carbachol induced bronchospasm. Journal of Allergy and Clinical Immunology. 69(1). 106–106. 1 indexed citations
15.
Mapp, C, et al.. (1979). [Toluene diisocyanate-induced asthma: specific and non-specific bronchial challenge tests (author's transl)].. PubMed. 70(3). 203–214. 7 indexed citations
16.
Mapp, C, Leonardo M. Fabbri, Alfredo Rossi, G Moro, & Giovanni Cervi. (1978). [Respiratory functional changes caused by chronic exposure to monomeric and polymeric vinyl chloride].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 69(2). 151–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026